01
GENERATE A BRIEF
LAB 03 — AUTONOMOUS AGENT FOR C-SUITE BRIEFING
Monday Brief
This agent runs autonomously every Monday morning (Sydney, Australia), or you can generate reports on demand.
It investigates every at-risk account, looks at health scores, usage trends, recent feedback - then writes a C-Suite ready brief.
02
RUN STATUS
Run #233
Live trace
I'll start by pulling flagged accounts and at-risk accounts simultaneously, then dig into the details.
→ 0 items
→ 10 items
Ten at-risk accounts returned. I'll now pull health, usage trends, and recent feedback for the three most critical (health scores 32, 39, 54) in parallel.
→ keys: name, health, usage_trend_pct
→ keys: name, health, usage_trend_pct
→ keys: name, health, usage_trend_pct
→ keys: name, usage_trend_pct
→ keys: name, usage_trend_pct
→ keys: name, usage_trend_pct
→ 3 items
→ 3 items
→ 3 items
All data collected. No flagged accounts were returned by the system. Here is the brief.
03
MONDAY BRIEF
The brief
Monday Risk Brief — All Segments
No accounts are currently carrying an open review flag in the system. The three accounts below have been identified through health scores, usage trends, and feedback as the highest immediate churn risks.
1. Top Three Highest-Risk Accounts
Halberd Financial Group — Health 32, usage down 20%; customer has issued a 30-day ultimatum, is actively trialling competitor Waypoint Analytics, and has separately referenced competitor Perch AI as a better alternative on anomaly detection.
Tinker Supply Lab — Health 39, usage down 26% (the steepest decline in the at-risk cohort); a formal escalation is open over 11 false Fetch Radar alerts in two weeks, with an end-of-month deadline before the customer self-terminates.
Bridgeway Logistics Partners — Health 54, usage down 19%; three concurrent product failures (Fetch Link dropped webhook events, Fetch Radar false positives on seasonal patterns, Fetch Flow dashboard timeouts) with the customer already researching competitor Coriolis on integrations.
2. Talking Points for the CCO's Team
Fetch Radar anomaly detection is a shared failure across all three accounts. False positives and missed detections are cited in feedback from Halberd Financial Group, Tinker Supply Lab, and Bridgeway Logistics Partners independently. This is a product signal, not a configuration issue — support teams should stop deflecting it as customer-side.
Support quality is accelerating churn, not preventing it. All three accounts describe receiving canned, non-responsive replies across multiple tickets and multiple weeks. By the time customers reach this level of frustration, support has already had multiple opportunities to intervene and did not.
Competitors are named and being evaluated right now. Halberd Financial Group is actively trialling Waypoint Analytics and has referenced Perch AI. Bridgeway Logistics Partners is looking at Coriolis. These are not vague threats — customers have done the research and are in evaluation mode.
3. Recommended Actions
Halberd Financial Group — Executive intervention this week. The 30-day clock is already running. Assign an executive sponsor, call the account, and bring a concrete delivery commitment on CSV/scheduled export reliability. Do not send another written response without a live conversation first.
Tinker Supply Lab — Emergency escalation before Friday. The end-of-month self-termination threat is credible given the escalation language and usage cliff. Get engineering to reproduce the 11 Fetch Radar false-alert incidents and commit to a hotfix timeline — not a quarterly roadmap reference — this week.
Bridgeway Logistics Partners — Assign a dedicated CSM and open a cross-product incident. Three product surfaces are failing simultaneously (Fetch Link, Fetch Radar, Fetch Flow). Coordinate a single point of contact and a joint engineering triage rather than handling each ticket in isolation. Proactive outreach before the customer surfaces another issue is essential given they are already researching alternatives.
Product: prioritise Fetch Radar signal quality. Three independent accounts in one cohort citing the same false-positive and missed-detection problem warrants an urgent product review, not a backlog item.
04